Filing Flows

Filing Flows › Dare Bioscience (DARE) › Who owns the stock

Who owns Dare Bioscience (DARE) stock

29 funds reported Dare Bioscience (DARE) shares in their latest 13F filings, worth $4.2M in all. The largest holder is Vanguard Capital Management LLC ($1.4M). Last quarter 14 funds added to their stakes and 11 cut them.

Largest holders of DARE (13F)Largest holders of DARE (13F)Vanguard Capital Management LLC$1.4MVanguard Group$1.0MAMH Equity$488KGeode Capital Management, LLC$296KUS Bancorp$255KVanguard Fiduciary Trust$193KBlackRock$136KState Street$100KJane Street Group, LLC$76KNorthern Trust$72K

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Capital Management LLC640,877$1.4Mincrease2026-06-30
Vanguard Group523,053$1.0Mincrease2025-12-31
AMH Equity232,373$488Kincrease2025-09-30
Geode Capital Management, LLC140,093$296Kdecrease2026-06-30
US Bancorp120,920$255Kincrease2026-06-30
Vanguard Fiduciary Trust91,269$193Kincrease2026-06-30
BlackRock64,248$136Kincrease2026-06-30
State Street47,415$100Kincrease2026-06-30
Jane Street Group, LLC36,092$76Knew2026-06-30
Northern Trust34,209$72Kincrease2026-06-30
Virtu Financial LLC15,803$33Knew2026-06-30
LPL Financial LLC14,889$31Kincrease2026-06-30
Raymond James Financial14,864$31Kdecrease2026-06-30
Price T Rowe Associates13,318$29Kincrease2026-06-30
UBS Group AG6,810$14Kdecrease2026-06-30

Dare Bioscience's latest quarter

Dare Bioscience, Q2 2026: revenue $188K, net loss $3.0M, operating cash flow −$6.8M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most DARE stock?

By the latest 13F filings: Vanguard Capital Management LLC ($1.4M); Vanguard Group ($1.0M); AMH Equity ($488K); Geode Capital Management, LLC ($296K); US Bancorp ($255K).

What is the short interest in DARE?

1,143,697 shares were sold short at the 2026-10-15 settlement, 24.04% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.